Cargando…
Intranasal Administration of Recombinant Mycobacterium smegmatis Inducing IL-17A Autoantibody Attenuates Airway Inflammation in a Murine Model of Allergic Asthma
Asthma is a chronic inflammatory disorder, previous studies have shown that IL-17A contributes to the development of asthma, and there is a positive correlation between the level of IL-17A and the severity of disease. Here, we constructed recombinant Mycobacterium smegmatis expressing fusion protein...
Autores principales: | Xu, Wanting, Chen, Ling, Guo, Sheng, Wu, Liangxia, Zhang, Jianhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790942/ https://www.ncbi.nlm.nih.gov/pubmed/26974537 http://dx.doi.org/10.1371/journal.pone.0151581 |
Ejemplares similares
-
Self-assembled chitosan nanoparticles for intranasal delivery of recombinant protein interleukin-17 receptor C (IL-17RC): preparation and evaluation in asthma mice
por: Lv, Yongli, et al.
Publicado: (2021) -
Intranasal administration of Lignosus rhinocerotis (Cooke) Ryvarden (Tiger Milk mushroom) extract attenuates airway inflammation in murine model of allergic asthma
por: Muhamad, Siti Aminah, et al.
Publicado: (2019) -
Mixed Mycobacterium kansasii and Mycobacterium smegmatis infection in an adult‐onset immunodeficiency patient with anti‐interferon‐γ autoantibodies
por: Chou, Yun‐Tse, et al.
Publicado: (2023) -
Expression of recombinant Mycobacterium bovis antigen 85B by Mycobacterium smegmatis mc(2)
por: Soares, Amanda, et al.
Publicado: (2014) -
Effect of intranasal rosiglitazone on airway inflammation and remodeling in a murine model of chronic asthma
por: Lee, Hwa Young, et al.
Publicado: (2016)